tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Tango Therapeutics prices 21M shares at $8.66 in underwritten offering
PremiumThe FlyTango Therapeutics prices 21M shares at $8.66 in underwritten offering
4d ago
Tango Therapeutics announces positive data from Phase 1/2 study of vopimetostat
Premium
The Fly
Tango Therapeutics announces positive data from Phase 1/2 study of vopimetostat
4d ago
Tango Therapeutics granted orphan designation for treatment of malignant glioma
Premium
The Fly
Tango Therapeutics granted orphan designation for treatment of malignant glioma
10d ago
Tango Therapeutics initiated with an Overweight at Piper Sandler
PremiumThe FlyTango Therapeutics initiated with an Overweight at Piper Sandler
2M ago
Tango Therapeutics Reports Q2 2025 Financial Results
Premium
Company Announcements
Tango Therapeutics Reports Q2 2025 Financial Results
3M ago
Tango Therapeutics reports Q2 EPS (35c), consensus (34c)
Premium
The Fly
Tango Therapeutics reports Q2 EPS (35c), consensus (34c)
3M ago
Biotech Alert: Searches spiking for these stocks today
PremiumThe FlyBiotech Alert: Searches spiking for these stocks today
5M ago
Tango Therapeutics announces first patient dosed in TNG456 Phase 1/2 trial
Premium
The Fly
Tango Therapeutics announces first patient dosed in TNG456 Phase 1/2 trial
5M ago
Tango Therapeutics: Promising Developments and Strategic Focus Justify Buy Rating
Premium
Ratings
Tango Therapeutics: Promising Developments and Strategic Focus Justify Buy Rating
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100